跳至主要内容
临床试验/JPRN-UMIN000041493
JPRN-UMIN000041493已完成未知

A multi-institutional, retrospective, translational study of the relationship between histological immune-related signatures and clinical benefit of paclitaxel + bevacizumab therapy in HER2-negative advanced breast cancer - TRI-BE study

The Mt.Fuji Foundation for Healthcare Innovation and Cluster Development Pharma Valley Center0 个研究点目标入组 156 人开始时间: 2020年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
156